WHO Patient Safety Curriculum Guide - Extranet Systems - World ...

1701678–1686.
24Runciman B, Merry A, Walton M. Safety and ethics in
health carea guide to getting it right, 1st ed. London,
Ashgate Publishers Ltd, 2007.
25Andrews LB et al. An alternative strategy for studying
adverse events in medical care. Lancet, 1997, 349309–
313.
26Runciman W. Iatrogenic injury in Australiaa report
prepared by the Australian Patient Safety Foundation.
Adelaide, Australian Patient Safety Foundation, 2001
http//www.apsf.net.au/accessed 23 February 2011.
27Eisenberg JM. Statement on medical errors. Before the
Senate Appropriations Subcommittee on Labor, Health
and Human Services and Education. Washington, DC, 13
December, 1999.
28Thomas E, Brennan T. Errors and adverse events in
medicinean overview. InVincent C, ed. Clinical risk
managementenhancing patient safety. London, BMJ
Books, 2002.
29Haywood R, Hofer T. Estimating hospital deaths due to
medical errorspreventability is in the eye of the reviewer.
Journal of the American Medical Association, 2001, 286
415–420.
30Thomas E, Studdert D, Brennan T. The reliability of medical
record review for estimating adverse event rates. Annals of
Internal Medicine, 2002, 136812–816.
31McDonald C, Weiner M, Sui H. Deaths due to medical
errors are exaggerated in Institute of Medicine report.
Journal of the American Medical Association, 2000, 248
93–95.
32Turner BA. The organizational and inter organisational
development of disasters. Administrative Science
Quarterly, 1976, 21378–397.
33Turner BA. Man-made disasters London, Wykeham
Science Press, 1978.
34Reason J. The contribution of latent human failures to the
breakdown of complex systems. Philosophical
Transactions of the Royal Society of London. Series B
Biological Sciences, 1990, 327475–484.
35Reason JT. Human error. New York, Cambridge University
Press, 1999.
36Pidgen N. Safety culturetransferring theory and evidence
from major hazards industries. Department of Transport
Behavioural Research in Road Safety, 10th Seminar,
London, 2001.
37International Atomic Energy Agency. The Chernobyl
accidentupdating of INSAG1. INSAG7International
Nuclear Safety GroupINSAG, 199224.
38Vaughan D. The Challenger launch decisionrisky
technology, culture and deviance at NASA. Chicago,
University of Chicago Press, 1996.
39Reason JT. Human errormodels and management. British
Medical Journal, 2000, 320768–770.
40Reason JT. Managing the risks of organisational accidents.
Aldershot, UK, Ashgate Publishing Ltd, 1997.
41Coombes ID et al. Why do interns make prescribing
errors A qualitative study. Medical Journal of Australia,
2008, 18889–94.
42Gault WG. Experimental exploration of implicit blame
attribution in the NHS. Edinburgh, Grampian University
Hospitals NHS Trust, 2004.
43Millenson ML. Breaking bad news Quality and Safety in
Health Care, 2002, 11206–207.
44Gault W. Blame to aim, risk management in the NHS. Risk
Management Bulletin, 2002, 76–11.
45Berwick D M. Improvement, trust and the health care
workforce. Quality and Safety in Health Care, 2003, 12
Suppl. 1i2i6.
46Walton M. Creating a 'no blame' cultureHave we got the
balance right Quality and Safety in Health Care, 2004,
13163–164.
47Maurino DE, Reason J, Johnson N, Lee RB. Beyond
aviation human factors Aldershot, UK, Ashgate Publishing
Ltd, 1995.
48Perrow C. Normal accidentsliving with high-technologies,
2nd ed. Princeton, NJ, Princeton University Press, 1999.
49Douglas M. Risk and blameessays in cultural theory.
London, Routledge, 1992.
50Helmreich RL, Merritt AC. Culture at work in aviation and
medicine. Aldershot, UK, Ashgate Publishing, 1998.
51Strauch B. Normal accidentsyesterday and today. In
Hohnson CW, ed. Investigating and reporting of accidents.
Washington, DC, National Transportation Safety Board,
2002.
52Emanuel L et al. What exactly is patient safety In
Henriksen K, Battles J B, Keyes M A, Grady ML, eds.
Advances in patient safetynew directions and alternative
approaches. Rockville, MD, Agency for Healthcare
Research and Quality, 200819-35.
53Vincent C. Patient safety, 2nd ed. London, Blackwell,
2010.
54Hicks LK et al. Understanding the clinical dilemmas that
shape medical students ethical development
Questionnaire survey and focus group study. British
Medical Journal, 2001, 322709–710.
トピック1のスライド: 患 者 安 全 とは
患 者 安 全 について 学 生 に 教 えるうえでは, 常 に 講
義 が 最 善 の 方 法 になるとは 限 らない. 講 義 を 検 討 す
る 場 合 は,その 中 で 学 生 に 対 話 や 討 論 をさせるのが
良 いアイデアとなる. 事 例 研 究 を 用 いれば,グルー
プ 討 論 の1つのきっかけが 生 まれる.もう1つの 方
法 は, 本 トピックに 関 係 する 問 題 をもたらす 医 療 の
さまざまな 側 面 について 学 生 に 質 問 することであ
る.たとえば, 非 難 の 文 化 ,エラーの 本 質 , 他 産 業 で
のエラーの 管 理 方 法 などについて 質 問 するとよい
であろう.
トピック1のスライドは, 指 導 者 が 本 トピックの 内
容 を 学 生 に 教 える 際 に 役 立 つよう 作 成 されており,
各 地 域 の 環 境 や 文 化 に 合 わせて 変 更 してもよい.
全 てのスライドを 使 用 する 必 要 はなく, 教 育 セッショ
ンに 含 まれる 内 容 に 合 わせて 調 整 するのが 最 も 有
効 となる.
使 用 した 薬 剤 名 については, 全 てWHOが 制 定 し
た 薬 物 の 国 際 一 般 名
(WHO International Nonproprietary
Names for Pharmaceutical Substances)
(http://www.who.int/medicines/services/
inn/en/;2011 年 3 月 24 日 現 在 )に 従 った.
109 Part B トピック 1: 投 薬 の 安 全 性 を 改 善 する